Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder

NCT00903045 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Propiverine hydrochloride
DRUG: Placebo

Sponsor

Samsung Medical Center